{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T22:46:54Z","timestamp":1757630814180,"version":"3.44.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.bonr.2025.101838","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T21:08:53Z","timestamp":1742850533000},"page":"101838","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Bone mineral density and microarchitecture improvement in a young patient with Hajdu-Cheney syndrome and autosomal dominant polycystic kidney disease treated with alendronate"],"prefix":"10.1016","volume":"25","author":[{"given":"Andr\u00e9 Silva","family":"Franco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria de Falco","family":"Caparbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elieser Hitoshi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa Maria Rodrigues","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Fernando","family":"Onuchic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bonr.2025.101838_bb0005","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bone.2016.08.025","article-title":"Hajdu Cheney syndrome; report of a novel NOTCH2 mutation and treatment with denosumab","volume":"92","author":"Adami","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2025.101838_bb0010","article-title":"Hajdu Cheney syndrome; a novel NOTCH2 mutation in a Syrian child, and treatment with zolidronic acid: a case report and a literature review of treatments","volume":"71","author":"Ahmad","year":"2021","journal-title":"Ann Med Surg (Lond)."},{"issue":"1","key":"10.1016\/j.bonr.2025.101838_bb0015","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1038\/s41598-019-40761-w","article-title":"PKD1 duplicated regions limit clinical utility of whole exome sequencing for genetic diagnosis of autosomal dominant polycystic kidney disease","volume":"9","author":"Ali","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bonr.2025.101838_bb0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10067-016-3459-7","article-title":"Acro-osteolysis","volume":"36","author":"Botou","year":"2017","journal-title":"Clin. Rheumatol."},{"issue":"4","key":"10.1016\/j.bonr.2025.101838_bb0025","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/1096-8628(20010515)100:4<292::AID-AJMG1308>3.0.CO;2-4","article-title":"Hajdu--Cheney syndrome: evolution of phenotype and clinical problems","volume":"100","author":"Brennan","year":"2001","journal-title":"Am. J. Med. Genet."},{"issue":"4","key":"10.1016\/j.bonr.2025.101838_bb0030","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1074\/jbc.M115.685453","article-title":"Hajdu Cheney mouse mutants exhibit osteopenia, increased Osteoclastogenesis, and bone resorption","volume":"291","author":"Canalis","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bonr.2025.101838_bb0035","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1210\/en.2016-1787","article-title":"An antibody to Notch2 reverses the Osteopenic phenotype of Hajdu-Cheney mutant male mice","volume":"158","author":"Canalis","year":"2017","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.bonr.2025.101838_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105613","article-title":"NOTCH2 promotes osteoclast maturation and metabolism and modulates the transcriptome profile during osteoclastogenesis","volume":"300","author":"Canalis","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.bonr.2025.101838_bb0045","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/jbmr.4668","article-title":"Early-onset osteoporosis: rare monogenic forms elucidate the complexity of disease pathogenesis beyond type I collagen","volume":"37","author":"Costantini","year":"2022","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bonr.2025.101838_bb0050","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00198-015-3314-8","article-title":"Capillaroscopic findings in a case of Hajdu-Cheney syndrome","volume":"27","author":"Damian","year":"2016","journal-title":"Osteoporos. Int."},{"issue":"9","key":"10.1016\/j.bonr.2025.101838_bb0055","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin. Proc."},{"issue":"2","key":"10.1016\/j.bonr.2025.101838_bb0060","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s40618-023-02179-0","article-title":"Bone fragility and osteoporosis in children and young adults","volume":"47","author":"Formosa","year":"2024","journal-title":"J. Endocrinol. Investig."},{"issue":"241","key":"10.1016\/j.bonr.2025.101838_bb0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1259\/0007-1285-21-241-42","article-title":"Cranio-skeletal dysplasia","volume":"21","author":"Hajdu","year":"1948","journal-title":"Br. J. Radiol."},{"issue":"2","key":"10.1016\/j.bonr.2025.101838_bb0070","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/ng0695-151","article-title":"The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains","volume":"10","author":"Hughes","year":"1995","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.bonr.2025.101838_bb0075","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ng.778","article-title":"Truncating mutations in the last exon of NOTCH2 cause a rare skeletal disorder with osteoporosis","volume":"43","author":"Isidor","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bonr.2025.101838_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.115850","article-title":"Bisphosphonates impair the onset of bone formation at remodeling sites","volume":"145","author":"Jensen","year":"2021","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.bonr.2025.101838_bb0085","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1210\/jc.2012-1027","article-title":"Benefits and risks of bisphosphonate therapy for osteoporosis","volume":"97","author":"Khosla","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.bonr.2025.101838_bb0090","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00198-023-06668-z","article-title":"Exploratory use of romosozumab for osteoporosis in a patient with Hajdu-Cheney syndrome: a case report","volume":"34","author":"Kim","year":"2023","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bonr.2025.101838_bb0095","doi-asserted-by":"crossref","unstructured":"Li S, Xu W, Xing Z, Qian J, Chen L, Gu R, Guo W, Lai X, Zhao W, Li S, Wang Y, Wang QJ, Deng F. A conditional knockout mouse model reveals a critical role of PKD1 in osteoblast differentiation and bone development. Sci. Rep. 2017;7:40505. doi:https:\/\/doi.org\/10.1038\/srep40505.","DOI":"10.1038\/srep40505"},{"issue":"21","key":"10.1016\/j.bonr.2025.101838_bb0100","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1093\/hmg\/10.21.2385","article-title":"Comparison of Pkd1-targeted mutants reveals that loss of polycystin-1 causes cystogenesis and bone defects","volume":"10","author":"Lu","year":"2001","journal-title":"Hum. Mol. Genet."},{"issue":"10","key":"10.1016\/j.bonr.2025.101838_bb0105","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/humu.21546","article-title":"Mutations in NOTCH2 in families with Hajdu-Cheney syndrome","volume":"32","author":"Majewski","year":"2011","journal-title":"Hum. Mutat."},{"issue":"2","key":"10.1016\/j.bonr.2025.101838_bb0110","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/ki.2010.375","article-title":"Patients with autosomal dominant polycystic kidney disease have elevated fibroblast growth factor 23 levels and a renal leak of phosphate","volume":"79","author":"Pavik","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.bonr.2025.101838_bb0115","doi-asserted-by":"crossref","unstructured":"Pittaway JFH, Harrison C, Rhee Y, Holder-Espinasse M, Fryer AE, Cundy T, Drake WM, Irving MD. Bisphosphonate therapy for spinal osteoporosis in Hajdu-Cheney syndrome - new data and literature review. Orphanet J Rare Dis. 2018Apr 4;13(1):47. doi:https:\/\/doi.org\/10.1186\/s13023-018-0795-5. Erratum in: Orphanet J. Rare Dis. 2019;14(1):104. doi:https:\/\/doi.org\/10.1186\/s13023-019-1084-7.","DOI":"10.1186\/s13023-019-1084-7"},{"issue":"5","key":"10.1016\/j.bonr.2025.101838_bb0120","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"issue":"11","key":"10.1016\/j.bonr.2025.101838_bb0125","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1210\/jc.2017-01102","article-title":"Bone structural characteristics and response to bisphosphonate treatment in children with Hajdu-Cheney syndrome","volume":"102","author":"Sakka","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bonr.2025.101838_bb0130","doi-asserted-by":"crossref","unstructured":"Sakka SD. Osteoporosis in children and young adults. Best Pract. Res. Clin. Rheumatol. 2022 Sep;36(3):101776. doi:https:\/\/doi.org\/10.1016\/j.berh.2022.101776.","DOI":"10.1016\/j.berh.2022.101776"},{"issue":"4","key":"10.1016\/j.bonr.2025.101838_bb0135","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ng.779","article-title":"Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss","volume":"43","author":"Simpson","year":"2011","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.bonr.2025.101838_bb0140","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40520-024-02826-3","article-title":"Recommendations for the optimal use of bone forming agents in osteoporosis","volume":"36","author":"Veronese","year":"2024","journal-title":"Aging Clin. Exp. Res."},{"issue":"1","key":"10.1016\/j.bonr.2025.101838_bb0145","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1749-6632.2009.05239.x","article-title":"Role of the polycytin-primary cilia complex in bone development and mechanosensing","volume":"1192","author":"Xiao","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"8","key":"10.1016\/j.bonr.2025.101838_bb0150","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00198-013-2298-5","article-title":"Mutations in NOTCH2 in patients with Hajdu-Cheney syndrome","volume":"24","author":"Zhao","year":"2013","journal-title":"Osteoporos. Int."}],"container-title":["Bone Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187225000154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187225000154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T20:08:08Z","timestamp":1757534888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352187225000154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":30,"alternative-id":["S2352187225000154"],"URL":"https:\/\/doi.org\/10.1016\/j.bonr.2025.101838","relation":{},"ISSN":["2352-1872"],"issn-type":[{"type":"print","value":"2352-1872"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone mineral density and microarchitecture improvement in a young patient with Hajdu-Cheney syndrome and autosomal dominant polycystic kidney disease treated with alendronate","name":"articletitle","label":"Article Title"},{"value":"Bone Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bonr.2025.101838","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101838"}}